Reduced Intensity Conditioning: Clinical Trials

1 trial of Reduced Intensity Conditioning, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Terminated 1

Follow Reduced Intensity Conditioning: new trials by email Literature Review of Reduced Intensity Conditioning trials Research Report on Reduced Intensity Conditioning

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dose-reduced Versus Standard Conditioning in MDS/sAML
Reduced Intensity Conditioning, Myeloablative conditioning - Myelodysplastic Syndromes, Secondary Acute Myeloid Leukemia
Phase 3TerminatedEuropean Society for Blood and Marrow Transplantation1292004-05-012015-04-03

Conditions studied

Myelodysplastic Syndromes (1)

Sponsors

European Society for Blood and Marrow Transplantation (1)

Countries

Germany (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Russia (1)

Top investigators

Afanasyer Boris (1)  ·  Allione Bernardino (1)  ·  Augustin Ferrant, MD (1)  ·  Axel R Zander, MD (1)  ·  Dietger Niederwieser, MD (1)  ·  Domink Heim, Prof. (1)  ·  Gerhard Behre (1)  ·  Ghulam J Mufti, MD (1)  ·  Giorgio Lambertenghi Deliliers (1)  ·  Kai Hubel (1)  ·  Kathrin Haifa Al-Ali, MD (1)  ·  Liisa Volin, MD (1)  ·  Marie Robin, MD (1)  ·  Martin Gramatzlle (1)

NIH funding

2005 (1)